BaroFold is a biopharmaceutical company focused on the development of protein therapeutics for immunology indications.
BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company's goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMTâ„¢ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 29, 2007 | Series A | $12M | 1 | — | — | Detail |
Mar 1, 2006 | Series Unknown | $2.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Peierls Foundation | — | Series A |